Dexcom G7 Continuous Glucose Monitoring (CGM) System

FDA 510(k) K231081 · Dexcom, Inc.

Substantially Equivalent

510(k) numberK231081

Submission

Device name
Dexcom G7 Continuous Glucose Monitoring (CGM) System
Applicant
Dexcom, Inc.
San Diego, CA, US
Received
April 17, 2023
Decision date
May 15, 2023
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QBJ – Integrated Continuous Glucose Monitoring System, Factory Calibrated
Device class
Class II (moderate risk)
Regulation
21 CFR 862.1355
Specialty
Clinical Chemistry

An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with…

Other 510(k)s with product code QBJ

510(k)DeviceApplicantDecision
K261402Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose…QBJ · Traditional Dexcom, Inc.06/08/2026SE
K253737Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous…QBJ · Traditional Dexcom, Inc.02/03/2026SE
K253710Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous…QBJ · Special Dexcom, Inc.12/17/2025SE
K243214Dexcom G7 15 Day Continuous Glucose Monitoring SystemQBJ · Traditional Dexcom, Inc.04/09/2025SE
K240902Dexcom G7 Continuous Glucose Monitoring SystemQBJ · Special Dexcom, Inc.04/23/2024SE
K233537FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose…QBJ · Traditional Abbott Diabetes Care, Inc.04/23/2024SE
K234133Dexcom G7 Continuous Glucose Monitoring SystemQBJ · Traditional Dexcom, Inc.02/26/2024SE
K223435FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose…QBJ · Traditional Abbott Diabetes Care, Inc.04/13/2023SE
K222447FreeStyle Libre 2 Flash Glucose Monitoring System; Freestyle Libre 3 Continuous Glucose…QBJ · Traditional Abbott Diabetes Care, Inc.03/03/2023SE
K223931Dexcom G6 Continuous Glucose Monitoring (CGM) SystemQBJ · Special Dexcom, Inc.01/11/2023SE

More from Dexcom, Inc.

510(k)DeviceDecision
K262472Stelo Glucose Biosensor SystemSBH · Special 08/11/2026SE
K260935Stelo Glucose Biosensor SystemSBH · Traditional 06/12/2026SE
K261402Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose…QBJ · Traditional 06/08/2026SE
K261359Stelo Glucose Biosensor SystemSAF · Special 05/21/2026SE
K253737Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous…QBJ · Traditional 02/03/2026SE
K253710Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous…QBJ · Special 12/17/2025SE
K252818Dexcom Smart BasalQRX · Traditional 11/18/2025SE
K243214Dexcom G7 15 Day Continuous Glucose Monitoring SystemQBJ · Traditional 04/09/2025SE
K240902Dexcom G7 Continuous Glucose Monitoring SystemQBJ · Special 04/23/2024SE
K234070Stelo Glucose Biosensor SystemSAF · Traditional 03/05/2024SE

Questions and answers

When was Dexcom G7 Continuous Glucose Monitoring (CGM) System cleared by the FDA?

Dexcom G7 Continuous Glucose Monitoring (CGM) System (K231081) received a 510(k) decision of Substantially Equivalent on May 15, 2023, 28 days after the submission was received.

What is the product code of K231081?

The FDA product code is QBJ – Integrated Continuous Glucose Monitoring System, Factory Calibrated, a Class II (moderate risk) device regulated under 21 CFR 862.1355.